Tart Cherry Extract is a polyphenol-rich botanical concentrate derived from Prunus cerasus, most commonly the Montmorency cultivar. Unlike sweet cherries, tart cherries contain significantly higher concentrations of anthocyanins and other bioactive compounds, which are the primary drivers of the extract's therapeutic effects. The extract is standardized to deliver consistent anthocyanin content across capsule, powder, and liquid forms.

The anthocyanins in tart cherry extract inhibit cyclooxygenase (COX-1 and COX-2) enzymes — the same molecular targets as NSAIDs — thereby reducing prostaglandin-driven inflammation and oxidative stress in muscle and joint tissue. Additionally, tart cherries are one of the few whole foods with measurable melatonin content, contributing to sleep-onset and sleep-duration benefits through direct melatonin receptor activation. The extract also inhibits xanthine oxidase, an enzyme central to uric acid production, providing a mechanistic rationale for its use in gout prevention.

Capsules and softgels (typically 480–500 mg standardized extract equivalent to ~240 mL juice) offer the most convenient and sugar-free dosing. Liquid concentrate (e.g., 30–60 mL diluted in water) delivers a broader phytochemical profile but includes natural sugars. Powders are useful for addition to smoothies or recovery shakes. Juice form is widely studied in RCTs but contains roughly 25 g sugar per 240 mL serving, which should be factored into diabetic care.

• Exercise-induced muscle soreness (DOMS)
• Sleep disturbance and insomnia
• Gout and hyperuricemia
• Osteoarthritis pain
• Post-exercise inflammation

• Recurrent gout flares (supported by Zhang et al. 2012 case-crossover data showing 35% risk reduction with cherry consumption)
• Exercise-associated immune suppression (anthocyanins attenuate post-exercise immune perturbation markers in trained athletes)

• Montmorency tart cherries (fresh or frozen) — The primary whole-food source; fresh Montmorency cherries contain the highest anthocyanin concentrations (~13–17 mg anthocyanins per 100 g) and the native melatonin profile that drives clinical outcomes.
• Tart cherry juice (unsweetened, 100%) — The most widely studied food-form in RCTs; 240 mL twice daily delivers a therapeutic anthocyanin dose, though it includes natural sugars (~25 g per serving).
• Balaton cherries — A darker, Hungarian-origin variety of Prunus cerasus with high anthocyanin content comparable to Montmorency; less studied clinically but shares the same core phytochemical profile.
• Sweet cherries (Prunus avium, e.g., Bing) — Lower anthocyanin concentration than tart varieties but still measurably reduce plasma urate (Jacob et al. 2003); useful as a complementary dietary source.
• Dark-pigmented berries (blueberries, blackcurrants, elderberries) — Rich in related anthocyanins (cyanidin, delphinidin glycosides) with overlapping COX-inhibitory and antioxidant activity; support the same anti-inflammatory pathways when tart cherries are unavailable.

• Mild gastrointestinal discomfort (bloating, nausea) at higher doses
• Loose stools or diarrhea with liquid concentrate or juice forms
• Elevated blood sugar with high-volume juice consumption in diabetic individuals
• Theoretical mild sedation when combined with sleep medications
• Allergic reactions (rare) in individuals with Prunus fruit allergies

• Recommended daily: Extract (standardized): 480–500 mg twice daily (equivalent to ~240 mL tart cherry juice per dose). Juice concentrate: 30 mL concentrate diluted in water twice daily. Whole juice: 240–480 mL daily in divided doses. Anthocyanin target: 80–120 mg per dose.
• Best time of day: For sleep: one dose 1–2 hours before bed. For exercise recovery: one dose 1–2 hours before training and one dose within 2 hours post-exercise. For gout or general anti-inflammatory use: morning and evening with meals.
• With or without food: Can be taken with or without food; taking with food reduces the likelihood of gastrointestinal discomfort, particularly in sensitive individuals.
• Time to effect: Acute soreness and sleep benefits: 3–7 days. Anti-inflammatory and uric acid benefits: 4–6 weeks of consistent use.
• How long to take it: Safe for continuous use in the doses studied. Most RCTs run 7 days to 12 weeks without cycling. For ongoing gout prevention or sleep support, long-term daily use is reasonable. No formal cycling requirement established, but periodic breaks (e.g., 1 month off every 6 months) are a conservative approach.